Held in Oxford on September 18th, this ELRIG event will look at what researchers are doing to support patients with fibrosis as well as the novel targets and modalities currently being explored and how are they being tested.
Professor Jagdeep Nanchahal from the Kennedy institute, Professor Nicholas Barnes from Celentyx and Dr Breda Twomey from UCB have all been confirmed as speakers at the event.
Bob Humphries and Simon Cruwys of TherapeutAix will be present at the networking event to discuss the unique insights from across academia, biotech and the pharma industry, as well as to catch up with contacts and make new connections.
To find out more about the event, and to register, click here.
We have worked extensively in fibrotic diseases including NASH and rare disease and orphan indications, such as IPF. You can find out more about our work in the area of fibrotic disease here.